ASX 200

Energy stocks hold the winning yield in Morningstar's outlook for dividend picks.

After a blistering rally in small caps, Glenmore is trimming winners, backing structural growers and doubling down on valuation discipline.

We unpack an overlooked sector of the market and shine a light on a small cap ASX stock pick which is currently flying under the radar.

Global Biotech is surging as policy fears fade and innovation takes centre stage. Here’s what’s driving the comeback into 2026.

Xero won Australia by riding the shift to cloud. But in the US, Intuit’s scale, data and regulatory depth make it almost untouchable.

Promotions, fallen angels, and real earnings power. Ausbil’s David Lloyd reveals what’s shaping the mid-cap universe at the moment.

A decade of rising utilisation is coming. Anna Milne outlines the forces reshaping healthcare and the stocks positioned to win.

VanEck’s ALFA ETF blends data, computing power and long/short discipline to find winners and shorts across the ASX. Here’s what drives it.

With giant returns come giant risks.

The panic is real, but the price cuts are better. Find out why the smart money is ignoring the noise and hunting for bargains.

Does the case for diversification into global banks still stack up for income-seeking investors?

Kyle De Souza shares his path from hard-rock mining to financial markets, offering insights on leadership and WA’s resources sector.

Proof that the ASX can host world-leading tech companies, shareholders are trimming Xero for struggling against Intuit in the US.

Macquarie says investors should prepare to become greedy as markets become fearful.

Predicting the big rain doesn’t count, building an ark does

After soaring to US$4,400, gold has paused. What comes next for the world’s oldest hedge?

From ETFs and trusts to insurance bonds and crypto, here’s what their portfolios look like.

Australian dividend worship risks mortgaging the future, with ASX 200 ETFs as collateral damage.

Leading brokers are consensus bearish on a few big ASX names (including CBA). Here are the key arguments for why consensus says "sell".

Westpac is the best of the bunch, while the disappointment has been a surprise to many.

Small caps are back and beating the big end of town. Can the rally last, or will momentum fade as we roll into 2026?

QVG Capital’s Chris Prunty shares the traits of market greats and reveals four small caps he believes could join their ranks.

A famous ASX contrarian trade from a decade ago is back in focus.

How have investors fared since the last Oasis tour in 2005?